MDGSW (Medigus) OCF Yield %: -28.08 (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MDGSW Medigus Ltd MDGSW
12 GF Score
Price $0.02
! 6 Warning Signs
View Full Analysis

What is Medigus OCF Yield %?

Medigus MDGSW 12 OCF Yield % is -28.08 as of Sep. 09, 2026. GuruFocus rates MDGSW with a GF Score™ of 12/100. The stock has 6 warning signs investors should review.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Medigus's Trailing 12-Month Cash Flow from Operations is $-1.82 Mil, and Market Cap is $0.00 Mil. Therefore, Medigus's OCF Yield % for today is -28.08%.

The historical rank and industry rank for Medigus's OCF Yield % or its related term are showing as below:

MDGSW' s OCF Yield % Range Over the Past 10 Years
Min: -1096.71   Med: -73.98   Max: -18.83
Current: -28.08


During the past 13 years, the highest OCF Yield % of Medigus was -18.83%. The lowest was -1096.71%. And the median was -73.98%.

MDGSW's OCF Yield % is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 1.82 vs MDGSW: -28.08

Medigus's OCF Margin % for the quarter that ended in Dec. 2024 was %.


Medigus OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Medigus OCF Yield % Related Terms


Medigus OCF Yield % Historical Data

* Premium members only.

The historical data trend for Medigus's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medigus OCF Yield % Chart

Medigus Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Medigus Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

MDGSW vs RMSL, HSDT, ALRTF: OCF Yield % Comparison

For the Medical Devices subindustry, Medigus's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medigus OCF Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medigus's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Medigus's OCF Yield % falls into.


MDGSW
12GF Score
Medigus Ltd MDGSW
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medigus OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Medigus's OCF Yield % for the fiscal year that ended in Dec. 2024 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-1.824 /
=N/A%

Medigus's annualized OCF Yield % for the quarter that ended in Dec. 2024 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-1.584 * 2 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -28.08 mean?
Medigus (MDGSW) has a OCF Yield % of -28.08 as of Sep. 09, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Medigus and its competitors.
Is Medigus' OCF Yield % too high?
Medigus' current OCF Yield % is -28.08. Overall, Medigus has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Medigus' OCF Yield % compare to RMSL and HSDT?
Medigus' OCF Yield % of -28.08 can be compared against companies in the Medical Devices & Instruments industry. The industry median OCF Yield % is 1.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Medical Devices & Instruments company?
The median OCF Yield % among Medical Devices & Instruments companies is 1.82, based on 849 companies in the industry. Companies in the top quartile (top 25%) have a OCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Medigus and its competitors. For the Medical Devices & Instruments industry, the median OCF Yield % is 1.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medigus's current OCF Yield % is -28.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medigus stock overvalued right now?
Medigus (MDGSW) has a current OCF Yield % of -28.08. The current OCF Yield % is -28.08. Medigus' overall GF Score™ is 12/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Medigus (MDGSW), the current OCF Yield % is -28.08 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Medigus Business Description

Address 10 Hanechoshet Street, 4th Floor, Tel Aviv, ISR, 6971072
Xylo Technologies Ltd is an Israel-based medical device company. The company is engaged in the development, manufacturing, and marketing of direct vision systems for minimally invasive medical procedures and safety systems for drones and the electric vehicle (EV) sector. The key product of the company is the MUSE (Medigus Ultrasonic Surgical Endostapler) system is a single-use device for the incision-less treatment of GERD (gastroesophageal reflux disease), which is based on proprietary platform technology and know-how. The company operates in four segments are: Corporate, Online advertising & internet traffic routing, Online event management, real-estate and electronics. The company's geographical segments include USA, Europe, Great Britain, Israel, Canada, Asia and others.
12GF Score

Get the complete analysis for MDGSW

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.02
Price